250 related articles for article (PubMed ID: 29682089)
1. Large-scale analysis of
Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.
Shenker NS; Flower KJ; Wilhelm-Benartzi CS; Dai W; Bell E; Gore E; El Bahrawy M; Weaver G; Brown R; Flanagan JM
BMC Cancer; 2015 May; 15():337. PubMed ID: 25927974
[TBL] [Abstract][Full Text] [Related]
3. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
Conway K; Edmiston SN; Tse CK; Bryant C; Kuan PF; Hair BY; Parrish EA; May R; Swift-Scanlan T
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):921-30. PubMed ID: 25809865
[TBL] [Abstract][Full Text] [Related]
4. CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.
Martín-Sánchez E; Mendaza S; Ulazia-Garmendia A; Monreal-Santesteban I; Blanco-Luquin I; Córdoba A; Vicente-García F; Pérez-Janices N; Escors D; Megías D; López-Serra P; Esteller M; Illarramendi JJ; Guerrero-Setas D
Oncotarget; 2017 Feb; 8(9):15789-15801. PubMed ID: 28178655
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.
Zhang M; Zhang S; Wen Y; Wang Y; Wei Y; Liu H; Zhang D; Su J; Wang F; Zhang Y
PLoS One; 2015; 10(11):e0142279. PubMed ID: 26550991
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint CD155 promoter methylation profiling reveals cancer-associated behaviors within breast neoplasia.
Triki H; Declerck K; Charfi S; Ben Kridis W; Chaabane K; Ben Halima S; Sellami T; Rebai A; Berghe WV; Cherif B
Cancer Immunol Immunother; 2022 May; 71(5):1139-1155. PubMed ID: 34608548
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the Gene Body in
Shen HT; Hung CS; Davis C; Su CM; Liao LM; Shih HM; Lee KD; Ansar M; Lin RK
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785978
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients.
Wu ZH; Tang Y; Zhou Y
Cancer Control; 2021; 28():1073274820988519. PubMed ID: 33504182
[TBL] [Abstract][Full Text] [Related]
9.
Wu HT; Wu Z; Hou YY; Fang ZX; Wu BX; Deng Y; Cui YK; Liu J
Epigenomics; 2023 Sep; 15(18):911-925. PubMed ID: 37905439
[No Abstract] [Full Text] [Related]
10. Machine learning unveils an immune-related DNA methylation profile in germline DNA from breast cancer patients.
Lee NY; Hum M; Tan GP; Seah AC; Ong PY; Kin PT; Lim CW; Samol J; Tan NC; Law HY; Tan MH; Lee SC; Ang P; Lee ASG
Clin Epigenetics; 2024 May; 16(1):66. PubMed ID: 38750495
[TBL] [Abstract][Full Text] [Related]
11. Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies.
Bodelon C; Ambatipudi S; Dugué PA; Johansson A; Sampson JN; Hicks B; Karlins E; Hutchinson A; Cuenin C; Chajès V; Southey MC; Romieu I; Giles GG; English D; Polidoro S; Assumma M; Baglietto L; Vineis P; Severi G; Herceg Z; Flanagan JM; Milne RL; Garcia-Closas M
Breast Cancer Res; 2019 May; 21(1):62. PubMed ID: 31101124
[TBL] [Abstract][Full Text] [Related]
12. Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent.
Yang Y; Wu L; Shu XO; Cai Q; Shu X; Li B; Guo X; Ye F; Michailidou K; Bolla MK; Wang Q; Dennis J; Andrulis IL; Brenner H; Chenevix-Trench G; Campa D; Castelao JE; Gago-Dominguez M; Dörk T; Hollestelle A; Lophatananon A; Muir K; Neuhausen SL; Olsson H; Sandler DP; Simard J; Kraft P; Pharoah PDP; Easton DF; Zheng W; Long J
J Natl Cancer Inst; 2020 Mar; 112(3):295-304. PubMed ID: 31143935
[TBL] [Abstract][Full Text] [Related]
13. Epigenome-wide DNA methylation and risk of breast cancer: a systematic review.
Ennour-Idrissi K; Dragic D; Durocher F; Diorio C
BMC Cancer; 2020 Oct; 20(1):1048. PubMed ID: 33129307
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.
Terry MB; McDonald JA; Wu HC; Eng S; Santella RM
Adv Exp Med Biol; 2016; 882():33-68. PubMed ID: 26987530
[TBL] [Abstract][Full Text] [Related]
15. PTPRT Could Be a Treatment Predictive and Prognostic Biomarker for Breast Cancer.
Li L; Xu F; Xie P; Yuan L; Zhou M
Biomed Res Int; 2021; 2021():3301402. PubMed ID: 34414233
[TBL] [Abstract][Full Text] [Related]
16. Methylation-to-Expression Feature Models of Breast Cancer Accurately Predict Overall Survival, Distant-Recurrence Free Survival, and Pathologic Complete Response in Multiple Cohorts.
Thompson JA; Christensen BC; Marsit CJ
Sci Rep; 2018 Mar; 8(1):5190. PubMed ID: 29581450
[TBL] [Abstract][Full Text] [Related]
17. A Joint Bayesian Model for Integrating Microarray and RNA Sequencing Transcriptomic Data.
Ma T; Liang F; Oesterreich S; Tseng GC
J Comput Biol; 2017 Jul; 24(7):647-662. PubMed ID: 28541721
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of DKK2 from the Dickkopf family in human breast cancer.
Shao YC; Nie XC; Song GQ; Wei Y; Xia P; Xu XY
Int J Oncol; 2018 Dec; 53(6):2555-2565. PubMed ID: 30320375
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel DNA methylation biomarkers for non-invasive sporadic breast cancer detection in the Latino population.
Cappetta M; Fernandez L; Brignoni L; Artagaveytia N; Bonilla C; López M; Esteller M; Bertoni B; Berdasco M
Mol Oncol; 2021 Feb; 15(2):473-486. PubMed ID: 33145876
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancy.
Park C; Jeong K; Park JH; Jung S; Bae JM; Kim K; Ock CY; Kim M; Keam B; Kim TM; Jeon YK; Lee SH; Lee JS; Kim DW; Kang GH; Chung DH; Heo DS
Cancer Immunol Immunother; 2021 Jun; 70(6):1605-1617. PubMed ID: 33230567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
